CAN
TXG icon

Cetera Advisor Networks’s 10x Genomics TXG Stock Holding History

Cetera Advisor Networks’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,235
Closed -$237K – 2930
2023
Q4 		$237K Buy
+4,235
New +$184K ﹤0.01% 2410
2022
Q1 		– Sell
-2,088
Closed -$311K – 2180
2021
Q4 		$311K Buy
2,088
+182
+10% +$27.9K ﹤0.01% 1582
2021
Q3 		$277K Buy
1,906
+209
+12% +$35.9K ﹤0.01% 1578
2021
Q2 		$332K Sell
1,697
-15
-0.9% -$2.71K ﹤0.01% 1443
2021
Q1 		$310K Buy
1,712
+30
+2% +$5.18K 0.01% 1115
2020
Q4 		$238K Buy
+1,682
New +$244K 0.01% 1177
2020
Q3 		– Sell
-100
Closed -$9K – 2899
2020
Q2 		$9K Buy
+100
New +$7.79K ﹤0.01% 2773

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Cetera Advisor Networks's TXG Position: Q1 2024 in Review

Cetera Advisor Networks sold out of 10x Genomics (TXG) in Q1 2024, closing a stake of 4,235 shares — an estimated $237K sold.

Cetera Advisor Networks first reported a position in TXG in Q2 2020 and held it in 7 quarters. The position peaked at $332K in Q2 2021. 290 funds tracked by Wall St. Rank hold TXG as of Q1 2024.

  • Cetera Advisor Networks reported no remaining 10x Genomics position as of Q1 2024 after selling out during the quarter.
  • Cetera Advisor Networks sold 4,235 10x Genomics shares in Q1 2024, an estimated $237K.
  • Cetera Advisor Networks first reported a position in 10x Genomics in Q2 2020 and held it in 7 quarters.
  • Cetera Advisor Networks's 10x Genomics position peaked at $332K in Q2 2021.
  • 290 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2024.

Based on Cetera Advisor Networks's 13F filing for Q1 2024, filed 15 May 2024.